FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890782740> ?p ?o ?g. }

• W2890782740 endingPage "24" @default.
• W2890782740 startingPage "19" @default.
• W2890782740 abstract "A strong, reciprocal crosstalk between inflammation and melanoma has rigorously been demonstrated in recent years, showing how crucial is a pro-inflammatory microenvironment to drive therapy resistance and metastasis.We investigated on the effects of Indicaxanthin, a novel, anti-inflammatory and bioavailable phytochemical from Opuntia Ficus Indica fruits, against human melanoma both in vitro and in vivo.The effects of indicaxanthin were evaluated against the proliferation of A375 human melanoma cell line and in a mice model of cutaneous melanoma. Cell proliferation was assessed by MTT assay, apoptosis by Annexin V-Fluorescein Isothiocyanate/Propidium Iodide staining, protein expression by western blotting, melanoma lesions were subcutaneously injected in mice with B16/F10 cells, chemokine release was quantified by ELISA.Data herein presented demonstrate that indicaxanthin effectively inhibits the proliferation of the highly metastatic and invasive A375 cells as shown by growth inhibition, apoptosis induction and cell invasiveness reduction. More interestingly, in vitro data were paralleled by those in vivo showing that indicaxanthin significantly reduced tumor development when orally administered to mice. The results of our study also clarify the molecular mechanisms underlying the antiproliferative effect of indicaxanthin, individuating the inhibition of NF-κB pathway as predominant.In conclusion, we demonstrated that indicaxanthin represents a novel phytochemical able to significantly inhibit human melanoma cell proliferation in vitro and to impair tumor progression in vivo. When considering the resistance of melanoma to the current therapeutical approach and the very limited number of phytochemicals able to partially counteract it, our findings may be of interest to explore indicaxanthin potential in further and more complex melanoma studies in combo therapy, i.e. where different check points of melanoma development are targeted." @default.
• W2890782740 created "2018-09-27" @default.
• W2890782740 creator A5005608086 @default.
• W2890782740 creator A5012386440 @default.
• W2890782740 creator A5028323346 @default.
• W2890782740 creator A5032477247 @default.
• W2890782740 creator A5039104297 @default.
• W2890782740 creator A5048901530 @default.
• W2890782740 creator A5052789682 @default.
• W2890782740 creator A5057541140 @default.
• W2890782740 creator A5057723638 @default.
• W2890782740 date "2018-11-01" @default.
• W2890782740 modified "2023-10-18" @default.
• W2890782740 title "Indicaxanthin from Opuntia Ficus Indica (L. Mill) impairs melanoma cell proliferation, invasiveness, and tumor progression" @default.
• W2890782740 cites W1543534779 @default.
• W2890782740 cites W1581923494 @default.
• W2890782740 cites W1757407923 @default.
• W2890782740 cites W1936108334 @default.
• W2890782740 cites W1966977448 @default.
• W2890782740 cites W1981636641 @default.
• W2890782740 cites W2003989043 @default.
• W2890782740 cites W2005647807 @default.
• W2890782740 cites W2008322756 @default.
• W2890782740 cites W2021309474 @default.
• W2890782740 cites W2025665129 @default.
• W2890782740 cites W2029810011 @default.
• W2890782740 cites W2031502153 @default.
• W2890782740 cites W2032890730 @default.
• W2890782740 cites W2038885723 @default.
• W2890782740 cites W2041377319 @default.
• W2890782740 cites W2051505863 @default.
• W2890782740 cites W2068854551 @default.
• W2890782740 cites W2091476343 @default.
• W2890782740 cites W2092153756 @default.
• W2890782740 cites W2093504658 @default.
• W2890782740 cites W2094110309 @default.
• W2890782740 cites W2098190175 @default.
• W2890782740 cites W2104210099 @default.
• W2890782740 cites W2117328824 @default.
• W2890782740 cites W2140693955 @default.
• W2890782740 cites W2406695003 @default.
• W2890782740 cites W2504029120 @default.
• W2890782740 cites W2589788277 @default.
• W2890782740 cites W2680456958 @default.
• W2890782740 cites W2745185511 @default.
• W2890782740 cites W81987094 @default.
• W2890782740 doi "https://doi.org/10.1016/j.phymed.2018.09.171" @default.
• W2890782740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30466978" @default.
• W2890782740 hasPublicationYear "2018" @default.
• W2890782740 type Work @default.
• W2890782740 sameAs 2890782740 @default.
• W2890782740 citedByCount "30" @default.
• W2890782740 countsByYear W28907827402019 @default.
• W2890782740 countsByYear W28907827402020 @default.
• W2890782740 countsByYear W28907827402021 @default.
• W2890782740 countsByYear W28907827402022 @default.
• W2890782740 countsByYear W28907827402023 @default.
• W2890782740 crossrefType "journal-article" @default.
• W2890782740 hasAuthorship W2890782740A5005608086 @default.
• W2890782740 hasAuthorship W2890782740A5012386440 @default.
• W2890782740 hasAuthorship W2890782740A5028323346 @default.
• W2890782740 hasAuthorship W2890782740A5032477247 @default.
• W2890782740 hasAuthorship W2890782740A5039104297 @default.
• W2890782740 hasAuthorship W2890782740A5048901530 @default.
• W2890782740 hasAuthorship W2890782740A5052789682 @default.
• W2890782740 hasAuthorship W2890782740A5057541140 @default.
• W2890782740 hasAuthorship W2890782740A5057723638 @default.
• W2890782740 hasConcept C121608353 @default.
• W2890782740 hasConcept C150903083 @default.
• W2890782740 hasConcept C190283241 @default.
• W2890782740 hasConcept C203014093 @default.
• W2890782740 hasConcept C207001950 @default.
• W2890782740 hasConcept C2775934118 @default.
• W2890782740 hasConcept C2777658100 @default.
• W2890782740 hasConcept C2779013556 @default.
• W2890782740 hasConcept C31573885 @default.
• W2890782740 hasConcept C502942594 @default.
• W2890782740 hasConcept C54355233 @default.
• W2890782740 hasConcept C55493867 @default.
• W2890782740 hasConcept C62112901 @default.
• W2890782740 hasConcept C86803240 @default.
• W2890782740 hasConcept C88634738 @default.
• W2890782740 hasConceptScore W2890782740C121608353 @default.
• W2890782740 hasConceptScore W2890782740C150903083 @default.
• W2890782740 hasConceptScore W2890782740C190283241 @default.
• W2890782740 hasConceptScore W2890782740C203014093 @default.
• W2890782740 hasConceptScore W2890782740C207001950 @default.
• W2890782740 hasConceptScore W2890782740C2775934118 @default.
• W2890782740 hasConceptScore W2890782740C2777658100 @default.
• W2890782740 hasConceptScore W2890782740C2779013556 @default.
• W2890782740 hasConceptScore W2890782740C31573885 @default.
• W2890782740 hasConceptScore W2890782740C502942594 @default.
• W2890782740 hasConceptScore W2890782740C54355233 @default.
• W2890782740 hasConceptScore W2890782740C55493867 @default.
• W2890782740 hasConceptScore W2890782740C62112901 @default.
• W2890782740 hasConceptScore W2890782740C86803240 @default.
• W2890782740 hasConceptScore W2890782740C88634738 @default.
• W2890782740 hasLocation W28907827401 @default.

• next